Raymond T Krediet Selected Research

Peritoneal Fibrosis

1/2022	Relative Contributions of Pseudohypoxia and Inflammation to Peritoneal Alterations with Long-Term Peritoneal Dialysis Patients.
1/2019	Early Detection of Imminent Encapsulating Peritoneal Sclerosis: Free Water Transport, Selected Effluent Proteins, or Both?
1/2018	Ultrafiltration Failure Is a Reflection of Peritoneal Alterations in Patients Treated With Peritoneal Dialysis.
11/2016	Identification of Gene Transcripts Implicated in Peritoneal Membrane Alterations.
5/2015	Peritoneal effluent MMP-2 and PAI-1 in encapsulating peritoneal sclerosis.
1/2014	The value of osmotic conductance and free water transport in the prediction of encapsulating peritoneal sclerosis.
10/2011	Imaging in encapsulating peritoneal sclerosis.
8/2011	Encapsulating peritoneal sclerosis: the state of affairs.
1/2011	The time course of peritoneal transport parameters in peritoneal dialysis patients who develop encapsulating peritoneal sclerosis.
1/2011	Experimental peritoneal sclerosis models should not be based on chlorhexidine gluconate anymore.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raymond T Krediet Research Topics

Disease

24	Peritoneal Fibrosis 01/2022 - 05/2004
17	Chronic Kidney Failure (Chronic Renal Failure) 01/2017 - 01/2002
16	Neoplasms (Cancer) 01/2022 - 01/2003
13	Peritonitis 09/2016 - 01/2002
11	Inflammation (Inflammations) 01/2022 - 01/2003
10	Fibrosis (Cirrhosis) 01/2017 - 02/2005
8	Chronic Renal Insufficiency 01/2017 - 11/2005
7	Infections 09/2016 - 08/2005
5	Renal Insufficiency (Renal Failure) 10/2021 - 03/2010
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 09/2008
4	Kidney Diseases (Kidney Disease) 01/2015 - 11/2005
4	Diabetes Mellitus 01/2014 - 01/2004
4	Body Weight (Weight, Body) 01/2009 - 01/2001
3	Hypoxia (Hypoxemia) 01/2022 - 10/2021
3	Water Intoxication 01/2021 - 08/2010
3	Obesity 06/2009 - 03/2007
2	Hyperemia 01/2021 - 03/2019
2	Anemia 10/2015 - 11/2014
2	Acute Kidney Injury (Acute Renal Failure) 12/2013 - 10/2006
2	Hereditary Nephritis (Alport Syndrome) 03/2010 - 01/2010
2	Anuria 06/2009 - 09/2005
1	Uremia 11/2016
1	Human Influenza (Influenza) 02/2016
1	Sclerosis 05/2015
1	Fistula 04/2013
1	Abdominal Pain (Pain, Abdominal) 01/2012
1	Acute-Phase Reaction 11/2011
1	Vascular Calcification 07/2011
1	Necrosis 04/2011

Drug/Important Bio-Agent (IBA)

21	Dialysis SolutionsIBA 11/2016 - 01/2003
19	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2003
13	AntigensIBA 01/2022 - 01/2003
13	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2001
11	CreatinineIBA 01/2021 - 03/2002
9	AlbuminsIBA 01/2021 - 11/2005
9	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2004
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2004
6	C-Reactive ProteinIBA 01/2021 - 11/2007
6	Lactic Acid (Lactate)FDA LinkGeneric 03/2010 - 01/2003
5	Biomarkers (Surrogate Marker)IBA 05/2015 - 01/2006
4	SolutionsIBA 01/2017 - 01/2004
4	Hemoglobins (Hemoglobin)IBA 10/2015 - 11/2005
4	Hyaluronic Acid (Hyaluronan)IBA 01/2015 - 01/2003
4	Serum AlbuminIBA 01/2014 - 09/2005
3	BuffersIBA 11/2016 - 01/2010
3	Immunoglobulin G (IgG)IBA 01/2016 - 01/2010
3	CalciumIBA 06/2012 - 11/2005
3	CA-125 Antigen (CA 125 Antigen)IBA 11/2011 - 12/2007
3	Amino Acids FDA Link 03/2011 - 01/2010
3	SodiumIBA 01/2011 - 01/2004
3	NitrogenIBA 06/2009 - 01/2001
3	Hydroxyproline (4 Hydroxyproline)IBA 09/2008 - 05/2004
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 07/2007
2	Connective Tissue Growth FactorIBA 01/2022 - 01/2022
2	Blood Proteins (Serum Proteins)IBA 01/2016 - 01/2006
2	Plasminogen Activator Inhibitor 1IBA 05/2015 - 09/2013
2	EnzymesIBA 01/2015 - 08/2010
2	Parathyroid Hormone (Parathormone)IBA 06/2012 - 11/2005
2	Erythropoietin FDA Link 06/2012 - 09/2005
2	Angiotensin Receptor AntagonistsIBA 01/2011 - 07/2007
2	Angiotensin IIIBA 11/2010 - 07/2007
2	Cystatin CIBA 08/2010 - 10/2006
2	Bicarbonates (Hydrogen Carbonate)IBA 03/2010 - 01/2010
2	Glycerol (Glycerine)FDA LinkGeneric 03/2010 - 01/2010
2	InterleukinsIBA 03/2010 - 11/2004
2	Phosphorus (Red Phosphorus)IBA 10/2007 - 11/2005
2	Urea (Carbamide)FDA LinkGeneric 04/2004 - 01/2001
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	NAD (NADH)IBA 01/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2022
1	PlasminogenIBA 01/2022
1	Guanosine Diphosphate (GDP)IBA 01/2022
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2022
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 10/2021
1	Crystalloid SolutionsIBA 01/2018
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2016
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 05/2015
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2015
1	insulin receptor-related receptor (IRR)IBA 12/2014
1	Mupirocin (Bactroban)FDA LinkGeneric 03/2014
1	A-factor (Streptomyces)IBA 01/2014
1	Plasminogen InactivatorsIBA 07/2013
1	alpha-2-HS-GlycoproteinIBA 04/2013
1	ProcalcitoninIBA 01/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2012
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2012
1	Glycoproteins (Glycoprotein)IBA 11/2011
1	CholesterolIBA 10/2011
1	Alkaline PhosphataseIBA 07/2011
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 03/2011

Therapy/Procedure

44	Peritoneal Dialysis 01/2022 - 01/2002
6	Therapeutics 06/2014 - 01/2002
5	Renal Dialysis (Hemodialysis) 05/2015 - 03/2007
5	Catheters 03/2014 - 06/2007
3	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2017 - 01/2012
3	Transplantation 01/2014 - 11/2003
3	Continuous Ambulatory Peritoneal Dialysis (CAPD) 03/2011 - 01/2003
2	Contraindications 03/2014 - 05/2004
2	Parenteral Infusions 01/2011 - 09/2010
1	Kidney Transplantation 12/2014